IL147201A0 - Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response - Google Patents

Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Info

Publication number
IL147201A0
IL147201A0 IL14720100A IL14720100A IL147201A0 IL 147201 A0 IL147201 A0 IL 147201A0 IL 14720100 A IL14720100 A IL 14720100A IL 14720100 A IL14720100 A IL 14720100A IL 147201 A0 IL147201 A0 IL 147201A0
Authority
IL
Israel
Prior art keywords
anticoagulant
surrogate markers
patient
treating
prevent
Prior art date
Application number
IL14720100A
Other languages
English (en)
Original Assignee
Rxfiles Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rxfiles Corp filed Critical Rxfiles Corp
Publication of IL147201A0 publication Critical patent/IL147201A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
IL14720100A 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response IL147201A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/348,592 US6267116B1 (en) 1999-07-06 1999-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
PCT/US2000/018576 WO2001002050A2 (en) 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Publications (1)

Publication Number Publication Date
IL147201A0 true IL147201A0 (en) 2002-08-14

Family

ID=23368686

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14720100A IL147201A0 (en) 1999-07-06 2000-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response

Country Status (15)

Country Link
US (2) US6267116B1 (de)
EP (1) EP1191894B1 (de)
JP (1) JP2003503165A (de)
KR (1) KR20020036790A (de)
CN (1) CN1359276A (de)
AT (1) ATE378015T1 (de)
AU (1) AU5919800A (de)
BR (1) BR0012241A (de)
CA (1) CA2362429C (de)
DE (1) DE60037116T2 (de)
IL (1) IL147201A0 (de)
MX (1) MXPA01013306A (de)
NO (2) NO20020043D0 (de)
TR (1) TR200103831T2 (de)
WO (1) WO2001002050A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
AU2001284868A1 (en) * 2000-08-24 2002-03-22 The Rxfiles Corporation Method and system for anticoagulant dose revision
US6578582B2 (en) * 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
US6883521B2 (en) * 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
WO2003026727A1 (en) * 2001-09-28 2003-04-03 Lifevent Limited sETHOD AND APPARATUS FOR DELIVERY OF MEDICATION
WO2005058373A2 (en) * 2003-12-12 2005-06-30 Petra Biotek, Inc. Methods, program products, and systems for single and multi-agent dosing
ES2356911T3 (es) * 2006-06-01 2011-04-14 Wila B.V. Herramienta con un dispositivo de seguridad automático.
EP1862255B1 (de) * 2006-06-01 2011-03-16 Wila B.V. Auswechselbares Werkzeug/Manipulator Kombination
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US8112290B2 (en) * 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
CA2744886C (en) * 2008-10-20 2018-11-13 Epitome Pharmaceuticals Limited Methods and systems for improved pharmaceutical intervention in coagulation control
US9057731B2 (en) 2010-06-23 2015-06-16 University Of Louisville Research Foundation, Inc. Methods and kits for predicting a response to an erythropoietic agent
WO2013049624A1 (en) 2011-09-30 2013-04-04 University Of Louisville Research Foundation, Inc. System and method for personalized dosing of pharmacologic agents
US10083400B2 (en) 2012-10-05 2018-09-25 Diane R. MOULD System and method for providing patient-specific dosing as a function of mathematical models updated to account for an observed patient response
EP3298519A1 (de) 2015-04-09 2018-03-28 Diane R. Mould Systeme und verfahren für patientenspezifische dosierung
US20190043501A1 (en) * 2017-08-02 2019-02-07 Elements of Genius, Inc. Patient-centered assistive system for multi-therapy adherence intervention and care management
US20230107786A1 (en) * 2021-10-05 2023-04-06 Bradford RABIN Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR20240033436A (ko) 2022-09-05 2024-03-12 박세경 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response

Also Published As

Publication number Publication date
BR0012241A (pt) 2002-03-26
JP2003503165A (ja) 2003-01-28
WO2001002050A3 (en) 2002-01-10
TR200103831T2 (tr) 2002-10-21
EP1191894B1 (de) 2007-11-14
CA2362429A1 (en) 2001-01-11
KR20020036790A (ko) 2002-05-16
CN1359276A (zh) 2002-07-17
NO20020043D0 (no) 2002-01-04
EP1191894A4 (de) 2004-10-20
MXPA01013306A (es) 2002-07-02
ATE378015T1 (de) 2007-11-15
NO20020056D0 (no) 2002-01-07
US6267116B1 (en) 2001-07-31
DE60037116D1 (de) 2007-12-27
US6942614B1 (en) 2005-09-13
NO20020056L (no) 2002-01-07
DE60037116T2 (de) 2008-09-11
AU5919800A (en) 2001-01-22
EP1191894A2 (de) 2002-04-03
WO2001002050A2 (en) 2001-01-11
CA2362429C (en) 2005-07-05

Similar Documents

Publication Publication Date Title
IL147201A0 (en) Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug response
ATE412445T1 (de) Stimulationssystem
NO996229D0 (no) Heparanase spesifikke molekylaere prober og deres anvendelse i forskning og medisin
SE8105081L (sv) System for behovsbaserad administration av insulin
DE60011274D1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
TW365526B (en) Relaxation aiding device and biological feedback aiding device
DE69802428D1 (de) Verfahren und gerät zur verminderung von alarmmisständen
WO2003011215A3 (en) Method and system to determine revised dosage
CA2316887A1 (en) Osmotic drug delivery monitoring system and method
WO2002082972A3 (en) Method and apparatus to optimize drug therapy
DE69925957D1 (de) Vorrichtung zur pulsartigen Verabreichung von Stickoxid mit genauer Dosis sowie Überwachunggerät und Alarmanlagen
HUP9802264A2 (hu) A vér oxigénszintjének mérésére szolgáló rendszer
DE69333641D1 (de) Methode zur messung der knochenresorption
BR0108516A (pt) Cronômetro de alarme eletrônico para uso em um tratamento médico
SE0102147D0 (sv) New methods
EP1162457A3 (de) Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung
DE69718169T2 (de) Test zur diagnose von schizophrenie mittels niacin
PT87997A (pt) Processo para a preparacao de composicoes farmaceuticas uteis para a correccao de vias metabolicas aberrantes associadas com ciclos de crescimento descontrolados de celulas tumorais e de virus contendo arn de dupla cadeia
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
PT841939E (pt) Agentes terapeuticos e doencas auto-imunes
DE3875826D1 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
HUP9903688A2 (hu) Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására
UA32167A (uk) Спосіб прогнозування появи негативної реакції крові при плануванні магнітотерапії, лазеротерапії, увч-терапії у хворих з травматичним переломом та остеомієлітом нижньої щелепи
UA31366A (uk) Пристрій для визначення кровотоку в біологічних тканинах
RU97101024A (ru) Способ оценки хирургической агрессии при операциях на брюшной полости